Spots Global Cancer Trial Database for fdg
Every month we try and update this database with for fdg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer | NCT06284070 | Cancer | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | ||
Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer | NCT06284070 | Cancer | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | ||
Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer | NCT01621529 | Infiltrating Du... | 18 Years - | Centre Henri Becquerel | ||
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy | NCT02317393 | Non-seminomatou... Metastasis | K5-RGD PET FDG | 18 Years - | Centre Francois Baclesse | |
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer | NCT00576563 | Rectum Cancer | FDG | 18 Years - | Maastricht Radiation Oncology | |
11C-Acetate PET/CT Non-FDG-Avid Tumors | NCT00687778 | Soft Tissue Sar... Thyroid Cancer Lung Cancer Indolent Lympho... Neuroendocrine ... GIST Uterine Maligna... Carcinoma, Hepa... Carcinoma, Lobu... Teratoma | 18 Years - 90 Years | Tel-Aviv Sourasky Medical Center | ||
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) | NCT02130492 | Advanced Cancer | FDG | 21 Years - | Weill Medical College of Cornell University | |
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers | NCT02600442 | Breast Neoplasm... Breast Cancer | non interventio... | - | Assistance Publique - Hôpitaux de Paris | |
Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma | NCT00934505 | Oesophageal Can... | 18 Years - | Centre Henri Becquerel | ||
Positron Emission Tomography in Patients With Breast Cancer | NCT00001385 | Breast Neoplasm... | - | National Institutes of Health Clinical Center (CC) | ||
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy | NCT00424138 | Lung Cancer | FDG | 18 Years - | American College of Radiology Imaging Network | |
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma | NCT00828126 | Melanoma | PET-CT Scan | 18 Years - | M.D. Anderson Cancer Center | |
Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities | NCT00606931 | Breast Cancer | Stereo Navigato... | 25 Years - | Naviscan PET Systems | |
The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | NCT01000428 | Erlotinib Lung Cancer | 18 Years - 85 Years | Asan Medical Center | ||
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy | NCT03741231 | Melanoma NSCLC Positron-Emissi... Immunotherapy 18F-FDG | 18 Years - | University Hospital, Brest | ||
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy | NCT00424138 | Lung Cancer | FDG | 18 Years - | American College of Radiology Imaging Network | |
The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | NCT01000428 | Erlotinib Lung Cancer | 18 Years - 85 Years | Asan Medical Center | ||
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation | NCT00847509 | Lung Cancer Head and Neck C... | [F-18]FLT | 18 Years - | Siemens Molecular Imaging | |
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT | NCT01261585 | Bronchial Neopl... Carcinoma, Non-... | 18 Years - 75 Years | Centre Henri Becquerel | ||
Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging | NCT02462239 | Muscle-invasive... | Whole-body FDG ... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer | NCT06284070 | Cancer | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | ||
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer | NCT00576563 | Rectum Cancer | FDG | 18 Years - | Maastricht Radiation Oncology | |
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) | NCT02130492 | Advanced Cancer | FDG | 21 Years - | Weill Medical College of Cornell University | |
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers | NCT02600442 | Breast Neoplasm... Breast Cancer | non interventio... | - | Assistance Publique - Hôpitaux de Paris | |
Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer | NCT01621529 | Infiltrating Du... | 18 Years - | Centre Henri Becquerel | ||
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx | NCT00767273 | Pancreatic Canc... | PET Scan FLT FDG | 18 Years - | Stanford University |